Regulatory News
Wednesday, July 27, 2016
TauRx Alzheimer's drug fails in large study; some benefit seen
CHICAGO, July 27 (Reuters) - TauRx Pharmaceuticals'
experimental Alzheimer's drug LMTX failed to improve cognitive
and functional skills in patients with mild to moderate
Alzheimer's disease, a...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment